Theranexus Société Anonyme (ALTHX.PA)
EUR 0.64
(32.37%)
EUR 0.64
(32.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.31 Million | -5.37 Million | -6.24 Million | -5.74 Million | -5.06 Million | -5.59 Million |
| Net Income | -6.82 Million | -6.56 Million | -8.15 Million | -4.79 Million | -5.57 Million | -5.3 Million |
| Depreciation & Amortization | 256.26 Thousand | 332 Thousand | 1.2 Million | 376.17 Thousand | 154.06 Thousand | 55.2 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 255.29 Thousand | 1.06 Million | 409.1 Thousand | -931.36 Thousand | 204.98 Thousand | -350.02 Thousand |
| Other non-cash items | 256.2 Thousand | -206.66 Thousand | 288.05 Thousand | -394.34 Thousand | 151.18 Thousand | -1151.00 |
| Investing Cash Flow | -61.1 Thousand | 323.53 Thousand | -150.61 Thousand | -252.05 Thousand | -2.1 Million | -461.13 Thousand |
| Investments in PPE | -43.6 Thousand | -41.21 Thousand | -150.61 Thousand | -252.05 Thousand | -2.1 Million | -328.62 Thousand |
| Acquisitions | - | -397.14 Thousand | - | - | - | - |
| Investment purchases | -17.49 Thousand | -20.51 Thousand | - | - | - | -132.51 Thousand |
| Sales/Maturities of investments | - | 417.65 Thousand | - | - | 993.00 | - |
| Other Investing Activities | 1.00 | 364.75 Thousand | -135.28 Thousand | -250.21 Thousand | 1.00 | 1.00 |
| Financing Cash Flow | 2.17 Million | 1.63 Million | 7.71 Million | 7.75 Million | 1.45 Million | 3 Million |
| Debt repayment | -750.94 Thousand | -1.03 Million | -474.61 Thousand | -3.67 Million | -687.1 Thousand | -3 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.92 Million | 676.47 Thousand | 8.14 Million | 4.08 Million | 2.14 Million | - |
| Other Financing Activities | -2751.00 | 1.99 Million | 39.27 Thousand | 7.34 Million | 991.00 | 6 Million |
| Accounts receivables | 318.93 Thousand | 1.06 Million | 540.31 Thousand | 189.69 Thousand | -436.86 Thousand | -1.12 Million |
| Accounts payables | -63.64 Thousand | 95.4 Thousand | -140.71 Thousand | - | - | - |
| Inventory | - | - | 140.71 Thousand | - | - | - |
| Other working capital | -63.64 Thousand | -95.4 Thousand | -131.21 Thousand | -1.12 Million | 641.84 Thousand | 772.16 Thousand |
| Cash at beginning of period | 2.1 Million | 5.51 Million | 8.71 Million | 3.42 Million | 7.15 Million | 3.22 Million |
| Cash at end of period | 1.19 Million | 9.1 Million | 5.51 Million | 8.71 Million | 3.42 Million | 7.15 Million |
| Capital Expenditure | -43.6 Thousand | -41.21 Thousand | -150.61 Thousand | -252.05 Thousand | -2.1 Million | -328.62 Thousand |
| Effect of forex changes on cash | - | 7 Million | -4.5 Million | 1.00 | 1.99 Million | -4.00 |
| Net cash flow / Change in cash | -905.95 Thousand | 3.58 Million | -3.19 Million | 5.28 Million | -3.72 Million | 3.92 Million |
| Free Cash Flow | -6.36 Million | -5.41 Million | -6.4 Million | -5.99 Million | -7.17 Million | -5.92 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 100.8 Thousand | -6.82 Million | -3.18 Million | -3.64 Million | -6.56 Million | -3.27 Million |
| Depreciation & Amortization | 47.4 Thousand | 256.26 Thousand | 88.02 Thousand | 168.42 Thousand | 332 Thousand | 166.51 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -274.1 Thousand | 255.29 Thousand | 595.14 Thousand | -339.85 Thousand | 1.06 Million | 1.27 Million |
| Other non-cash items | -2.15 Million | 256.2 Thousand | -47.99 Thousand | 654.27 Thousand | -206.66 Thousand | -1.35 Million |
| Investing Cash Flow | -10.01 Thousand | -61.1 Thousand | -61.32 Thousand | 215.00 | 323.53 Thousand | 377.5 Thousand |
| Investments in PPE | -2176.00 | -43.6 Thousand | -2995.00 | -29.72 Thousand | -41.21 Thousand | -19.69 Thousand |
| Acquisitions | - | - | -29.93 Thousand | 29.93 Thousand | -397.14 Thousand | - |
| Investment purchases | - | -17.49 Thousand | -17.49 Thousand | - | -20.51 Thousand | -20.51 Thousand |
| Sales/Maturities of investments | 7692.00 | - | - | - | 417.65 Thousand | 417.65 Thousand |
| Other Investing Activities | -7836.00 | 1.00 | -58.32 Thousand | 1047.00 | 364.75 Thousand | 381.35 Thousand |
| Financing Cash Flow | -861.43 Thousand | 2.17 Million | 2.71 Million | -454.89 Thousand | 1.63 Million | -551.67 Thousand |
| Debt repayment | -831.46 Thousand | -750.94 Thousand | -300.6 Thousand | -450.34 Thousand | -1.03 Million | -223.95 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -323.52 Thousand |
| Common Stock Issuance | - | 2.92 Million | 2.92 Million | - | 676.47 Thousand | -323.52 Thousand |
| Other Financing Activities | -29.97 Thousand | -2751.00 | 2.71 Million | -4555.00 | 1.99 Million | -4197.00 |
| Accounts receivables | -232.43 Thousand | 318.93 Thousand | 675.39 Thousand | -356.46 Thousand | 1.06 Million | 1.06 Million |
| Accounts payables | - | -63.64 Thousand | - | - | 95.4 Thousand | 216.9 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -41.67 Thousand | -63.64 Thousand | -80.24 Thousand | 16.6 Thousand | -95.4 Thousand | -6867.00 |
| Cash at beginning of period | 4.9 Million | 2.1 Million | 4.79 Million | 2.1 Million | 5.51 Million | 4.54 Million |
| Cash at end of period | 1.75 Million | 1.19 Million | 1.19 Million | 796.2 Thousand | 9.1 Million | 2.1 Million |
| Capital Expenditure | -2176.00 | -43.6 Thousand | -2995.00 | -29.72 Thousand | -41.21 Thousand | -19.69 Thousand |
| Effect of forex changes on cash | - | - | - | 9.1 Million | 7 Million | -9.13 Million |
| Net cash flow / Change in cash | -3.15 Million | -905.95 Thousand | -3.59 Million | -1.3 Million | 3.58 Million | -2.43 Million |
| Free Cash Flow | -2.28 Million | -6.36 Million | -2.54 Million | -3.88 Million | -5.41 Million | -2.26 Million |
SGTM
SPFYF
SURYODAY
SALFACORP
CRH
RATNAVEER